Verified peer comparison
Arcutis Biotherapeutics vs Immunovant Financial Comparison
Direct answer
Arcutis Biotherapeutics and Immunovant are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Arcutis Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Arcutis Biotherapeutics Revenue
- 376,072,000 USD
- Immunovant Revenue
- 0 USD
- Arcutis Biotherapeutics Operating income
- -12,227,000 USD
- Immunovant Operating income
- -438,152,000 USD